Brain damage due to sustained elevations of bilirubin...no exact number on it....combination of factors...trauma due to birth (pre-hepatic) and immature liver (hepatic)
Kernicterus-- A potentially lethal disease of newborns caused by excessive accumulation of the bile pigment bilirubin.
The disorder is known as Kernicterus, which occurs when bilirubin levels become excessively high in newborns and lead to bilirubin deposition in the brain. This condition is often a result of severe jaundice and can cause serious neurological damage if not treated promptly. Kernicterus can result from various underlying issues, including blood type incompatibility and certain genetic disorders. Early detection and treatment of elevated bilirubin levels are crucial to prevent this serious complication.
kernicterus, a form of brain damage. Signs of severe hyperbilirubinemia include listlessness, high-pitched crying, apnea (periods of not breathing), arching of the back, and seizures
There is a possibility to cause oaf for those who takes sulfamethoxazole within the early 16 pregnant weeks, and kernicterus if the medicine is used several weeks before the pregnant is braught to bed. Therefore, it should only be used for the middle pregnant period.
In about 15% of cases, the baby is severely affected and dies before birth. Babies who survive pregnancy may develop kernicterus, which can lead to deafness, speech problems, cerebral palsy, or mental retardation.
Kernicterus or bilirubin encephalopathy is a rare neurological disorder characterized by excessive levels of bilirubin in the blood (hyperbilirubinemia) during infancy. Bilirubin is an orange-yellow bile pigment that is a byproduct of the natural breakdown of hemoglobin in red blood cells (hemolysis). Toxic levels of bilirubin may accumulate in the brain, potentially resulting in a variety of symptoms and physical findings.These symptoms may include lack of energy (lethargy), poor feeding habits, fever, and vomiting. Affected infants may also experience the absence of certain reflexes (e.g., Moro reflex, etc.); mild to severe muscle spasms including those in which the head and heels are bent backward and the body bows forward (opisthotonus); and/or uncontrolled involuntary muscle movements (spasticity). In some cases, infants with kernicterus may develop life-threatening complications.
A bilirubin level above 20 mg/dL is generally considered dangerous and can lead to serious complications, including kernicterus, especially in newborns. In adults, levels exceeding 30 mg/dL can be life-threatening and may indicate severe liver dysfunction or hemolysis. Prompt medical intervention is crucial to manage elevated bilirubin levels and prevent serious health consequences.
Excess bilirubin in a baby, known as jaundice, can lead to serious health issues if not treated promptly. High levels of bilirubin can cause brain damage, a condition called kernicterus, which may result in long-term neurological problems. Additionally, elevated bilirubin can indicate underlying health issues, such as liver dysfunction or hemolytic disease. Early detection and management are crucial to prevent complications.
In the fetus, bilirubin metabolism is limited due to the immature liver and the absence of adequate glucuronyl transferase enzymes, which are necessary for bilirubin conjugation. Instead, bilirubin is primarily transported to the placenta, where it is excreted into the maternal circulation for elimination. This process helps prevent bilirubin accumulation in the fetal bloodstream, which could lead to complications like kernicterus. After birth, the newborn's liver matures, enabling effective bilirubin metabolism and conjugation.
Blue lighting, or phototherapy, is used on jaundiced babies to help reduce high levels of bilirubin in their blood. The blue light breaks down bilirubin into a form that can be more easily excreted by the body. This treatment is effective and helps prevent serious complications associated with elevated bilirubin levels, such as kernicterus. The process is safe and typically requires the baby to be exposed to the light for several hours each day.
Excess bilirubin in the bloodstream, a condition known as hyperbilirubinemia, can lead to jaundice, characterized by yellowing of the skin and eyes. High levels of bilirubin can indicate underlying health issues, such as liver disease, bile duct obstruction, or hemolytic anemia. If untreated, severe hyperbilirubinemia can result in neurological complications, including kernicterus, particularly in newborns, which can lead to permanent damage to the brain. Monitoring and addressing elevated bilirubin levels is crucial for preventing these serious health risks.
Phototherapy is very effective in reducing bilirubin levels in the majority of infants who need it. There are usually no long-term effects on the child from the hyperbilirubinemia or the phototherapy